& Cohen, R
Integrating molecular risk assessment with individualized surgical planning may aid in reducing early intracranial progression and improving outcomes in this highly invasive tumor
Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers
Across preclinical work, the most consistent signals are Remodeling of the extracellular matrix, including collagen and elastin pathways Anti inflammatory actions and modulation of oxidative stress markers Support for repair processes in tissue and skin models Human clinical data exist, but they are limited in size and quality
It is prepared by compounding pharmacies using semaglutide as the active ingredient, but these products have not received FDA approval for safety, quality, or efficacy
Iossa S, Mollica MP, Lionetti L, Crescenzo R, Botta M, Barletta A, Liverini G